POMC and congenital adrenal hyperplasia: Under a GC-only treatment paradigm for CAH, to restore the HPA axis negative feedback loop and reduce excess ACTH and adrenal androgen production, supraphysiologic doses of GCs are typically required and may be associated with additional risks and side effects including decreased growth rates, impaired final adult height, and reduced bone health (28, 29, 34–37).